metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Prevalence of hepatitis B seropositivity among Thai workers in screening program...
Journal Information
Vol. 7. Issue 4.
Pages 389 (October - December 2008)
Share
Share
Download PDF
More article options
Vol. 7. Issue 4.
Pages 389 (October - December 2008)
Open Access
Prevalence of hepatitis B seropositivity among Thai workers in screening program before going abroad
Visits
1159
Mayuna Srisupanant1,
Corresponding author
mayunasrisup@hotmail.com

Address for correspondence:
, Viroj Wiwanitkit2
1 Faculty of Public Health, Mahidol University, Bangkok Thailand.
2 Wiwanitkit House, Bangkhae, Bangkok Thailand
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table I.. Annual prevalence of HBsAg + ve among workers who received screening HBV serology.
Full Text

Editor, hepatitis B virus (HBV) infection is an important viral infection. Chronic HBV infection can result in a very serious complication, hepatoma. HBV serology is a basic screening test in laboratory medicine at present.1 Of several serological parameters, HBs Ag is the suggested parameter for HBV screening. Since this test is easily available, therefore, this serological test is accepted as standard for HBV detection at present.2,3 HBsAg is still widely used tool for screening for HBV in Thailand. The standard main recommendations for screening are antenatal test and blood banking test. However, there are also other recommendations including screening for the workers who want to go abroad. In this work, the authors summarize the authors studied of HBs Ag seropositivity in Thai workers going aboard from a tertiary hospital in Thailand. The data on the screening HBV serology in Thai workers going aboard who visited the laboratory of Rajvithi Hospital Bangkok during 1994-2001 was reviewed (More recent data is not available therefore not reviewed). The screening method in this study is standard HBsAg blood test. The annual and overall prevalence were calculated.

According to this work, there are overall 221,093 workers participating in the HBV serology screening program. There is no modification in the age of included subjects along the time. The HBsAg + ve can be seen in 9,199 cases giving overall prevalence equal to 4.16 %. Considering the annual prevalence, the details are shown in Table I. In this work, the author tried to study the results of screening HBV serology in Thai workers going aboard. Since these workers have healthy external appearance, the result might also reflect the situation in healthy general population. Of interest, there is a clear reduction in the annual prevalence rates since 1994 until 2001. It might reflect the effect of universal vaccination at birth which is firstly implemented in Thailand in 1980's. According to this work, there are a considerable number of HBs Ag positive cases (4.16%) implying that HBV infection is still the main infectious disease in Thailand. The high rate of disclosed HBV infection also implies the possible high rate of future hepatoma cases. Of interest, the screening program is voluntary not compulsory for everybody who wants to emigrate. It is suggested that affected HBV cases can have relapse during hard work aboard, therefore, affected cases are suggested for no migration. In addition, the results may not directly reflect the actual situation on the Thai population, as many subjects aware of their HbsAg positive results may prefer to evitate this screening as they know that they will be counseled not to emigrate.

Table I..

Annual prevalence of HBsAg + ve among workers who received screening HBV serology.

Year  Number of screenees  Number of posivity  Annual prevalence 
1994  20,773  1,162  5.59 
1995  26,351  1,272  4.83 
1996  24,230  1,471  6.07 
1997  24,909  1,166  4.68 
1998  27,364  1,055  3.86 
1999  28,023  1,080  3.85 
2000  43,493  1,258  2.89 
2001  25,950  735  2.83 
Acknowledgement

The authors hereby would like to thank Ms. Sunee Singhanati, B.Sc. who give the data on the screening result for this work.

References
[1.]
Daikoku M..
Diagnostic tests: Serological markers of hepatitis B virus.
Nippon Rinsho, 63 (2005), pp. 404-407
[2.]
Lai C.L., Yuen M.F..
The natural history of chronic hepatitis B.
J Viral Hepat, 14 (2007), pp. 6-10
[3.]
Jones D.B., Koorey D.J..
Screening studies and markers.
Gastroenterol Clin North Am, 16 (1987), pp. 563-573
Copyright © 2008. Fundación Clínica Médica Sur, A.C.
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos